ß3-adrenergic receptor sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma

被引：0
|
作者：
Bruno, Gennaro [1 ]
Nastasi, Nicoletta [1 ]
Subbiani, Angela [1 ]
Boaretto, Alessia [1 ]
Tondo, Annalisa [1 ]
Favre, Claudio [1 ]
Calvani, Maura [1 ]
机构：
[1] Meyer Childrens Hosp Florence, Florence, Italy
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3887
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cdk5 disruption attenuates tumor PD-L1 expression via regulation of IFN-γ signaling components and promotes antitumor immunity
    Dorand, Rodney D., Jr.
    Nthale, Joseph
    Myers, Jay T.
    Barkauskas, Deborah S.
    Avril, Stefanie
    Chirieleison, Steven M.
    Pareek, Tej K.
    Abbott, Derek W.
    Stearns, Duncan S.
    Letterio, John J.
    Huang, Alex Y.
    Petrosiute, Agne
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [32] Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
    Topalian, Suzanne L.
    Drake, Charles G.
    Pardoll, Drew M.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) : 207 - 212
  • [33] Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer"
    Abiko, Kaoru
    Hamanishi, Junzo
    Matsumura, Noriomi
    Mandai, Masaki
    BRITISH JOURNAL OF CANCER, 2023, 128 (03) : 461 - 467
  • [34] Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after “IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer”
    Kaoru Abiko
    Junzo Hamanishi
    Noriomi Matsumura
    Masaki Mandai
    British Journal of Cancer, 2023, 128 : 461 - 467
  • [35] Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment
    Li, Jie
    Cao, Peiyu
    Chen, Yuxin
    Wang, Junqi
    Sun, Xiaolei
    Chen, Renfu
    Wang, Gang
    Hou, Jianquan
    EXPERIMENTAL CELL RESEARCH, 2022, 417 (01)
  • [36] Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells
    Zhou, Xinyi
    Fu, Dongliang
    Yang, Hang
    Le, Chenqin
    Lu, Yier
    Wei, Jingsun
    Tang, Yang
    Zhang, Jiawei
    Yuan, Ying
    Ding, Kefeng
    Xiao, Qian
    CANCER LETTERS, 2023, 577
  • [37] Pharmacokinetic analysis of anti-PD-1 and PD-L1 antibodies and evaluation of their anti-tumor effects
    Hatakeyama, Hiroto
    Kurino, Taiki
    Matsuda, Reiko
    Suzuki, Hiroyuki
    Terui, Ayu
    Uehara, Tomoya
    Arano, Yasushi
    Hisaka, Akihiro
    CANCER RESEARCH, 2019, 79 (13)
  • [38] IFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
    de Kleijn, Stan
    Langereis, Jeroen D.
    Leentjens, Jenneke
    Kox, Matthijs
    Netea, Mihai G.
    Koenderman, Leo
    Ferwerda, Gerben
    Pickkers, Peter
    Hermans, Peter W. M.
    PLOS ONE, 2013, 8 (08):
  • [39] Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma
    Numata, Yasunao
    Akutsu, Noriyuki
    Ishigami, Keisuke
    Koide, Hideyuki
    Wagatsuma, Kohei
    Motoya, Masayo
    Sasaki, Shigeru
    Nakase, Hiroshi
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 30
  • [40] Quantitative Assessment of PD-L1 Expression in Classical Hodgkin Lymphoma Suggests a Critical Role for Tumor Associated Macrophages in Suppressing Anti-Tumor Immunity
    Carey, Christopher Daniel
    Connelly, Courtney
    Gjini, Evisa
    Roemer, Margaretha G. M.
    Stack, Edward
    Hodi, Stephen
    Shipp, Margaret A.
    Rodig, Scott J.
    BLOOD, 2015, 126 (23)
12345